Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
AETHLON MEDICAL INC
Insider Steven P. LaRosa of Aethlon Medical Inc reported a change in beneficial ownership of company securities effective October 8, 2026. This filing serves as a Form 4 statement regarding the insider's equity holdings.…more
View filingShareAETHLON MEDICAL INC
Insider Chetan Shah of Aethlon Medical Inc has filed a report regarding his beneficial ownership of securities as of September 30, 2026. This filing serves as a standard disclosure of insider equity holdings.…more
View filingShareAETHLON MEDICAL INC
Insider Angela Rossetti of Aethlon Medical Inc has filed an amended Form 4/A regarding changes in beneficial ownership of securities for the reporting period of April 17, 2026. This filing serves to correct the previously reported details of the insider's equity holdings and transactions.…more
View filingShare16 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Aethlon Medical Announces Merger with North Immunology
Aethlon Medical has signed an all-stock merger agreement with North Immunology to form a new entity that will trade under the ticker NRTX. The deal includes a $180 million private placement and results in significant dilution for existing Aethlon shareholders.…more
●●●●●●●● ●●●●● ●●●●●●
Aethlon Medical will merge with North Immunology, resulting in significant dilution for existing Aethlon shareholders who will retain approximately 4.75% of the combined entity. The deal includes a $180 million private placement to fund the development of the company's lead bispecific antibody candidate through 2028.…more
●●●●●●●● ●●●●● ●●●●●●
Aethlon Medical has received a notice of allowance for a U.S. patent concerning devices and methods for treating viral infections. This development strengthens the company's intellectual property portfolio in the medical device sector.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.